InvestorsHub Logo
Followers 63
Posts 7611
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Wednesday, 05/31/2017 12:39:18 PM

Wednesday, May 31, 2017 12:39:18 PM

Post# of 430192
One Advantage of an 80% stop for efficacy would be the shock effect of a R-IT study stopped in its tracks with the purpose of saving lives of American patients. The FDA would have a tougher time pushing back on such a stop than if the study were to go to completion.(especially with the FDA having rescinded the SPA for Anchor)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News